Biocon Biopharmaceuticals Limited

Biocon Biopharmaceuticals Limited - life sciences in Bangalore, Karnataka, India. Directors, charges & compliance details.
CIN U24231KA2002PLC030643 Incorporated 17 June 2002 ROC Bangalore HQ Bangalore, Karnataka, India
Merged Public Limited Company life sciences
Authorised capital
₹44 Cr
Registered with MCA
Paid-up capital
₹17.6 Cr
Issued & subscribed
Company age
24 yrs
Est. 2002
Directors on board
4
As per MCA filings
Last financials
Mar 2013
Balance sheet date
Last AGM
25 Jul 2013
Annual general meeting
Company status
Amalgamated
MCA master data
Registrar
Bangalore
ROC office

About Biocon Biopharmaceuticals Limited

Data last updated:

Biocon Biopharmaceuticals Limited was a public limited company based in Bangalore, Karnataka, India. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the biotechnology segment of the life sciences sector. It was incorporated on 17 June 2002.

The company was registered with the Registrar of Companies (ROC), Bangalore, under CIN U24231KA2002PLC030643.

The company had an authorised share capital of ₹44 Cr and a paid-up capital of ₹17.6 Cr. It was led by directors including Kiran Mazumdar Shaw (Managing Director) and John Mccallum Marshall Shaw.

Its last annual general meeting (AGM) was held on 25 July 2013, and its latest financial statements are for the year ended 31 March 2013. The registered office was at 20th Km Hosur Road Electronic City P O Bangalore, Karnataka, India – 560100.

Court records list 2 cases involving the company, including 2 filed by the company. The company has 1 deal on record (1 acquisition); the latest was in March 2010.

The last known website on record is biocon.com.

Company details

CIN U24231KA2002PLC030643
Registration Number 030643
Incorporation Date 17 June 2002
ROC Bangalore
Listing Status Unlisted
Company Status Amalgamated

CIN history

Biocon Biopharmaceuticals has one previous CIN (Corporate Identification Number): U24231KA2002PTC030643. The current CIN is U24231KA2002PLC030643, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24231KA2002PLC030643Current
U24231KA2002PTC030643Previous

Contact details

Biocon Biopharmaceuticals Limited's registered office is in Bangalore, Karnataka.

  • Social Media
  • Registered Address
    20th Km Hosur Road Electronic City P O Bangalore, Karnataka, India – 560100
  • Industry
    Life Sciences, Biotechnology
Comprehensive company report
Biocon Biopharmaceuticals Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Biocon Biopharmaceuticals Limited

FY 2013 filings available

Financial Statement Summary

MetricsFY 2012-13
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA
Profit Before Tax
Tax Expense
Net Profit (PAT)
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2012-13
Profitability
EBITDA Margin
Net Profit Margin
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Biocon Biopharmaceuticals Limited, buy the company report.

Board of directors of Biocon Biopharmaceuticals Limited

Biocon Biopharmaceuticals has 4 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.

Directors (as last reported)
NameDesignationAppointment DateTenureStatus
Kiran Mazumdar ShawManaging Director17 Jun 200224 Years 4 MonthsAs last reported
John Mccallum Marshall ShawDirector17 Jun 200224 Years 4 MonthsAs last reported
Chinappa Muckatira BhemaiahAlternate Director22 Mar 200719 Years 7 MonthsAs last reported
Arun Suresh ChandavarkarNominee Director22 Mar 200719 Years 7 MonthsAs last reported

Deals & funding

Biocon Biopharmaceuticals Limited has 1 deal on record (1 acquisition); the latest was in March 2010.

Total deals
1
Acquisition
1

Deals on record (1 of 1)

WhenDealAmountParties
Mar 2010AcquisitionUndisclosedBuyer: Biocon Limited
Seller: CIMAB SA

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Biocon Biopharmaceuticals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Biocon Biopharmaceuticals Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Biocon Biopharmaceuticals Limited has 9 board changes on record since 2002: 4 appointments and 5 cessations. The latest: Antonio Emilio Vallin Garcia ceased to be Alternate Director on 28 Apr 2010.

AGM
Biocon Biopharmaceuticals Limited last Annual general meeting of members was held on 25 Jul 2013 as per latest MCA records.
Filing
Biocon Biopharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2013 with Roc Bangalore.
Ceased
Antonio Emilio Vallin Garcia ceased to be Alternate Director.
Ceased
Ernesto Chico Veliz ceased to be Nominee Director.
Ceased
Joaquin Manuel Villan Guerra ceased to be Nominee Director.
Ceased
Patricia De La Asuncion Sierra Blazquez ceased to be Nominee Director.
Appointed
Arun Suresh Chandavarkar was appointed as Nominee Director.
Appointed
Chinappa Muckatira Bhemaiah was appointed as Alternate Director.
Ceased
Kiran Mazumdar Shaw ceased to be Director.
Appointed
John Mccallum Marshall Shaw was appointed as Director.
Appointed
Kiran Mazumdar Shaw was appointed as Managing Director.
Incorporation
17 Jun 2002
Biocon Biopharmaceuticals Limited was registered on 17 Jun 2002 with Roc Bangalore & aged 24 years 4 months as per MCA records.

Frequently asked questions

Biocon Biopharmaceuticals has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.

Biocon Biopharmaceuticals was a public limited company based in Bangalore, Karnataka, India. The company worked in biotechnology, within the life sciences industry. It was incorporated on 17 June 2002 and is registered under CIN U24231KA2002PLC030643. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.

Biocon Biopharmaceuticals was incorporated on 17 June 2002. It is registered with the Registrar of Companies, Bangalore.

Biocon Biopharmaceuticals had 4 directors:

The CIN (Corporate Identification Number) of Biocon Biopharmaceuticals is U24231KA2002PLC030643. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

The registered office of Biocon Biopharmaceuticals is at 20th Km Hosur Road Electronic City P O Bangalore, Karnataka, India – 560100.

Biocon Biopharmaceuticals can be reached through the website biocon.com. Its registered office is in Bangalore, Karnataka, India.

The latest financial statements of Biocon Biopharmaceuticals on record with the MCA are for the year ended 31 March 2013. Its last annual general meeting was held on 25 July 2013. Year-wise statements from 2015 are in the company report.

Biocon Biopharmaceuticals operated in the life sciences industry, in the biotechnology segment.

Biocon Biopharmaceuticals has 1 deal on record (1 acquisition); the latest was in March 2010.